|
|
Volumn 152, Issue 1, 2005, Pages 189-191
|
|
Pioglitazone: A promising therapy for psoriasis [12]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ETRETIN;
FUMADERM;
FUMARIC ACID;
GLUCOCORTICOID;
HYDROXYUREA;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
PIOGLITAZONE;
RETINOID;
ROSIGLITAZONE;
TROGLITAZONE;
VITAMIN D DERIVATIVE;
CELL NUCLEUS RECEPTOR;
FUMARIC ACID ETHYL ESTER;
LIPID;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;
RETINOIC ACID RECEPTOR;
TRANSCRIPTION FACTOR;
ADULT;
ANEMIA;
BLOOD VESSEL TONE;
CELL PROLIFERATION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG INDICATION;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
DRUG SENSITIVITY;
DRUG TOLERABILITY;
EDEMA;
FATIGUE;
FEMALE;
FLUID RETENTION;
GASTROINTESTINAL SYMPTOM;
GENE ACTIVATION;
HEADACHE;
HEMATURIA;
HUMAN;
HYPOGLYCEMIA;
IMPOTENCE;
INFLAMMATION;
INSULIN SENSITIVITY;
INSULIN TREATMENT;
KERATINOCYTE;
LETTER;
LIPID BLOOD LEVEL;
LIPID METABOLISM;
LIVER DYSFUNCTION;
LIVER TOXICITY;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHOTOTHERAPY;
PILOT STUDY;
PRIORITY JOURNAL;
PROTEINURIA;
PSORIASIS VULGARIS;
SIDE EFFECT;
SODIUM RETENTION;
SWEATING;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VISUAL IMPAIRMENT;
WATER RETENTION;
WEIGHT GAIN;
CARDIOVASCULAR EFFECT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DIABETES MELLITUS;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG SAFETY;
DRUG WITHDRAWAL;
GENE CONTROL;
GENE EXPRESSION;
PSORIASIS;
RANDOMIZED CONTROLLED TRIAL;
ULTRAVIOLET RADIATION;
VISUAL DISORDER;
ADULT;
CHRONIC DISEASE;
DERMATOLOGIC AGENTS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
PPAR GAMMA;
PSORIASIS;
THIAZOLIDINEDIONES;
|
|
EID: 13244286538
PISSN: 00070963
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1365-2133.2005.06369.x Document Type: Letter |
|
Times cited : (46)
|
|
References (5)
|
